Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CV Risk”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Not applicableUnknownNCT04698447
What this trial is testing

The Role of a Natural Product, Containing Nanovesicles From Citrus Limon (L.) Juice, on Different CV Risk Factors

Who this might be right for
Metabolic SyndromeHealthy Volunteers
University of Palermo 60
Not applicableStudy completedNCT02714881
What this trial is testing

Lipids, Inflammation, and CV Risk in RA

Who this might be right for
Rheumatoid ArthritisCardiovascular Disease
Brigham and Women's Hospital 74
Early research (Phase 1)Looking for participantsNCT06446531
What this trial is testing

Prevention of Progression of Prediabetes, Obesity and CV Risk

Who this might be right for
Pre-DiabetesWeight, BodyCardiovascular Diseases
The University of Texas Health Science Center at San Antonio 64
Not applicableEnrolling By InvitationNCT07363980
What this trial is testing

Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid ArthritisAtherosclerotic Ischemic DiseasePulmonary Disease+14 more
Ellen Margrethe Hauge 4,000
Not applicableStudy completedNCT00006297
What this trial is testing

Risk Factors for CV Disease in a Dialysis Cohort

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableLooking for participantsNCT07356817
What this trial is testing

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

Who this might be right for
Cardiovascular (CV) RiskPreeclampsia (PE)Fetal Weight
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,260
Not applicableEnded earlyNCT04050982
What this trial is testing

Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction

Who this might be right for
Atrial Fibrillation
Stanford University 11
Large-scale testing (Phase 3)UnknownNCT03254446
What this trial is testing

Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension

Who this might be right for
DiabetesDyslipidemiasHypertension
Torrent Pharmaceuticals Limited 1,250
Not applicableLooking for participantsNCT06902857
What this trial is testing

Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)

Who this might be right for
Type 2 DiabetesCardiovascular Complication
Istituto Nazionale di Ricovero e Cura per Anziani 1,002
Not applicableLooking for participantsNCT06624046
What this trial is testing

Circadian Mechanisms, Glucose, and CV Risks in T1D

Who this might be right for
Type 1 Diabetes (T1D)
University of Illinois at Chicago 100
Not applicableEnded earlyNCT02898896
What this trial is testing

Coronary Artery Disease (CAD) in Suppressed HIV-infected

Who this might be right for
Virus-HIV
University Hospital, Montpellier 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07223385
What this trial is testing

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer Stage IVCV Risk
Cedars-Sinai Medical Center 80
Testing effectiveness (Phase 2)Temporarily pausedNCT02560805
What this trial is testing

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Who this might be right for
Stress Disorders, Post-Traumatic
Emory University 134
Large-scale testing (Phase 3)Looking for participantsNCT06383390
What this trial is testing

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Eli Lilly and Company 10,000
Not applicableLooking for participantsNCT07247487
What this trial is testing

Diet and Cardiometabolism in Rosario

Who this might be right for
Cardiovascular (CV) RiskNutritionCardiometabolic Health Indicators
Universidad del Centro Educativo Latinoamericano 105
Not applicableLooking for participantsNCT04005508
What this trial is testing

OSA and CV Outcomes in Patients With High Risk AF

Who this might be right for
Atrial FibrillationObstructive Sleep Apnea
National University of Singapore 1,365
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Not applicableLooking for participantsNCT07067398
What this trial is testing

Improving the Heart Health of Home Health Aides

Who this might be right for
CardiovascularCardiovascular (CV) RiskCardiovascular Disease (CVD) Risk Factors+1 more
Weill Medical College of Cornell University 40
Large-scale testing (Phase 3)Study completedNCT00799903
What this trial is testing

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Who this might be right for
Atherosclerosis
GlaxoSmithKline 15,828
Large-scale testing (Phase 3)Looking for participantsNCT05918861
What this trial is testing

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Who this might be right for
Acute Coronary Syndrome
DalCor Pharmaceuticals 2,000
Load More Results